Navigation Links
Statins OK for Patients With Abnormal Liver Function: Study
Date:11/24/2010

TUESDAY, Nov. 23 (HealthDay News) -- Long-term use of cholesterol-lowering statins does not increase the risk of liver disease in patients with abnormal liver function, and can actually improve liver function, according to a new study that challenges widespread belief.

The researchers also pointed out that this study is the first to show that statins provide a substantially greater cardiovascular benefit in patients with abnormal liver function than in those with normal liver function.

The study, published in the Nov. 24 online edition of The Lancet, included 437 patients with moderately abnormal liver tests believed to have non-alcoholic fatty liver disease. Statins were given to 227 patients, while the other 210 (the control group) received no treatment.

After three years of follow-up, the patients taking statins did not have a higher rate of liver problems than those in the control group. In addition, levels of alanine aminotransferase (ALT) -- a biomarker of liver problems -- decreased or normalized in the patients taking statins but worsened in the control group.

The investigators also found that patients with abnormal liver tests who took statins had a 39 percent to 68 percent reduced risk of cardiovascular events such as heart attack and stroke.

"The risk-to-benefit ratio of long-term statin treatment (mainly with atorvastatin in this study) favors statin administration even for patients with moderately abnormal liver tests," Vasilis Athyros, of the Hippokration University Hospital in Thessaloniki, Greece, Dr. Dimitri Mikhailidis, of University College London in the United Kingdom, and colleagues concluded.

More information

The American Liver Foundation explains how to care for your liver.

-- Robert Preidt

SOURCE: The Lancet, news release, Nov. 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins Dont Reduce Colon Cancer Risk, Study Finds
2. Statins did not reduce colorectal cancer in WHI analysis
3. Statins dont prove useful for general pediatric lupus population
4. Aspirin, Statins May Reduce Problems After Heart Surgery
5. Statins May Guard Against Rheumatoid Arthritis
6. Study Suggests Statins Could Help Some With Normal Cholesterol
7. Statins, Painkillers May Upset PSA Test Results
8. Some on Statins May Not Need Boost in Good Cholesterol
9. Statins May Not Be as Helpful for Those Without Heart Disease
10. Statins May Lower Rates of Prostate Cancer Recurrence
11. Statins associated with lower cancer recurrence following prostatectomy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins OK for Patients With Abnormal Liver Function: Study
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: